The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV+ African Americans

AIDS Research and Human Retroviruses

Volumn 30, Issue 3, 2014, Pages 233-240

  Howe, Chanelle J ^a   Cole, Stephen R ^b   Napravnik, Sonia ^b,c   Kaufman, Jay S ^d   Adimora, Adaora A ^b,c   Elston, Beth ^a   Eron Jr , Joseph J ^c   Mugavero, Michael J ^e  

^a BROWN UNIVERSITY   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MIDDLE AGED; PATIENT ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AFRICAN AMERICANS; ALABAMA; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS; VIRAL LOAD;

EID: 84895543221     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0163     Document Type: Article

References (43)

1. CDC: Fact Sheet: HIV Among African Americans. U.S. Department of Health and Human Services, Atlanta, 2011.
2. CDC: HIV/AIDS Statistics and Surveillance. www.cdc.gov/hiv/topics/ surveillance/index.htm. Accessed March 26, 2013.
3. Gulick RM, Ribaudo HJ, Shikuma CM, et al.: Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: A randomized controlled trial. JAMA 2006;296(7):769-781.
4. Mugavero MJ, Lin HY, Allison JJ, et al.: Racial disparities in HIV virologic failure: Do missed visits matter? J Acquir Immune Defic Syndr 2009;50(1):100-108.
5. Fullilove RE: African Americans, Health Disparities and HIV/AIDS: Recommendations for Confronting the Epidemic in Black America: National Minority AIDS Council 2006.
6. Cargill VA and Stone VE: HIV/AIDS: A minority health issue. Med Clin North Am 2005;89(4):895-912.
7. Catz SL, McClure JB, Jones GN, and Brantley PJ: Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care 1999;11(3):361-373.
8. Israelski D, Gore-Felton C, Power R, Wood MJ, and Koopman C: Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med 2001;33(5):470-475.
9. Kissinger P, Cohen D, Brandon W, Rice J, Morse A, and Clark R: Compliance with public sector HIV medical care. J Natl Med Assoc 1995;87(1):19-24.
10. Rastegar DA, Fingerhood MI, and Jasinski DR: Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care 2003;15(2):231-237.
11. Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, and Freedberg KA: Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr 2007; 44(1):30-37.
12. Robbins GK, Johnson KL, Chang Y, et al.: Predicting virologic failure in an HIV clinic. Clin Infect Dis 2010;50(5): 779-786.
13. Valdez H, Lederman MM, Woolley I, et al.: Human immunodeficiency virus 1 protease inhibitors in clinical practice: Predictors of virological outcome. Arch Intern Med 1999;159(15):1771-1776.
14. Lucas GM, Chaisson RE, and Moore RD: Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131(2):81-87.
15. Park WB, Choe PG, Kim SH, et al.: One-year adherence to clinic visits after highly active antiretroviral therapy: A predictor of clinical progress in HIV patients. J Intern Med 2007;261(3):268-275.
16. Cheever LW: Engaging HIV-infected patients in care: Their lives depend on it. Clin Infect Dis 2007;44(11):1500-1502.
17. Giordano TP, Gifford AL, White AC Jr, et al.: Retention in care: A challenge to survival with HIV infection. Clin Infect Dis 2007;44(11):1493-1499.
18. Mugavero MJ, Lin HY, Willig JH, et al.: Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009;48(2):248-256.
19. Andersen RM: Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995;36(1):1-10.
20. Messeri PA, Abramson DM, Aidala AA, Lee F, and Lee G:The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care 2002;14(Suppl 1):S15-29.
21. Chartier K and Caetano R: Ethnicity and health disparities in alcohol research. Alcohol Res Health 2010;33(1-2):152-160.
22. Saloner B and Le Cook B: Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Aff (Millwood) 2013; 32(1):135-145.
23. Mugavero MJ, Lin HY, Allison JJ, et al.: Failure to establish HIV care: Characterizing the "no show" phenomenon. Clin Infect Dis 2007;45(1):127-130.
24. Bush K, Kivlahan DR, McDonell MB, Fihn SD, and Bradley KA: The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158(16):1789-1795.
25. Kozak MS, Mugavero MJ, Ye J, et al.: Patient reported outcomes in routine care: Advancing data capture for HIV cohort research. Clin Infect Dis 2012;54(1):141-147.
26. Zou G and Donner A: Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res 2013;22(6):661-670.
27. Hernán MA, Hernandez-Diaz S, Werler MM, and Mitchell AA: Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am J Epidemiol 2002;155(2):176-184.
28. Hernán MA, Hernandez-Diaz S, and Robins JM: A structural approach to selection bias. Epidemiology 2004;15(5): 615-625.
29. Hernán MA, McAdams M, McGrath N, Lanoy E, and Costagliola D: Observation plans in longitudinal studies with time-varying treatments. Stat Methods Med Res 2009;18(1):27-52.
30. Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, and Eron JJ Jr: Splines for trend analysis and continuous confounder control. Epidemiology 2011;22(6):874-875.
31. Lucas GM, Gebo KA, Chaisson RE, and Moore RD: Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002;16(5):767-774.
32. Lo W, MacGovern T, and Bradford J: Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care 2002;14(Suppl 1):S45-57.
33. Mugavero MJ, Westfall AO, Zinski A, et al.: Measuring retention in HIV care: The elusive gold standard. J Acquir Immune Defic Syndr 2012;61(5):574-580.
34. Chan D, Absher D, and Sabatier S: Recipients in need of ancillary services and their receipt of HIV medical care in California. AIDS Care 2002;14(Suppl 1):S73-83.
35. Ashman JJ, Conviser R, and Pounds MB: Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care 2002;14(Suppl 1):S109-118.
36. Mugavero MJ, Davila JA, Nevin CR, and Giordano TP: From access to engagement: Measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS 2010; 24(10):607-613.
37. Smith-Rohrberg D, Mezger J, Walton M, Bruce RD, and Altice FL: Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S48-53.
38. Hernán MA and Cole SR: Invited Commentary: Causal diagrams and measurement bias. Am J Epidemiol 2009; 170(8):959-962; discussion 963-964.
39. Cole SR and Hernán MA: Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008;168(6):656-664.
40. Betancourt JR: Eliminating racial and ethnic disparities in health care: What is the role of academic medicine? Acad Med 2006;81(9):788-792.
41. Beach MC, Gary TL, Price EG, et al.: Improving health care quality for racial/ethnic minorities: A systematic review of the best evidence regarding provider and organization interventions. BMC Public Health 2006;6:104.
42. Lurie N: Health disparities-less talk, more action. N Engl J Med 2005;353(7):727-729.
43. Lurie N and Dubowitz T: Health disparities and access to health. JAMA 2007;297(10):1118-1121.